Biopsy Devices Market is projected to reach a CAGR of nearly 5.2% between 2024 and 2032

The global biopsy devices market size was valued at USD 23.69 billion in 2023 and is projected to reach USD 37.39 billion by 2032, with a compound annual growth rate (CAGR) of nearly 5.2% between 2024 and 2032.

Biopsy devices are medical tools designed to collect small tissue or cell samples from various parts of the human body, enabling doctors to accurately diagnose diseases and plan the most suitable treatment for patients. Unlike imaging tests such as X-rays or scans, biopsy devices allow doctors to examine actual tissue under a microscope, providing a more accurate and confirmed diagnosis. Common types include needle-based biopsy instruments, biopsy guidance systems, and vacuum-assisted biopsy devices, with each developed for different medical procedures and diagnostic requirements. These devices are widely used to detect breast, lung, prostate, liver, and colorectal cancers, as well as other medical conditions, in hospitals, diagnostic laboratories, specialty clinics, and research institutes worldwide. Rising cancer cases, growing awareness about early disease detection, increasing healthcare spending, and continuous improvements in diagnostic technology are encouraging healthcare providers to adopt biopsy devices for faster diagnosis, better treatment planning, and improved patient outcomes.

The biopsy devices industry is growing due to rising cancer incidence, increasing preference for minimally invasive procedures, and the wider adoption of image-guided diagnostic technology across developing healthcare systems.

Browse the full “Biopsy Devices Market By Product (Core Needle Biopsy, Aspiration Biopsy, and Vacuum Assisted Biopsy), By Application (Breast Biopsy, Prostrate Biopsy, and Lung Biopsy), And By Region- Global Industry Perspective, Comprehensive Analysis, and Forecast, 2024-2032” Report at https://www.zionmarketresearch.com/report/biopsy-devices-market

Market Growth Factors

Several factors are pushing growth in the biopsy devices market.

• Rising prevalence of cancer: A growing number of cancer cases worldwide is encouraging healthcare providers to use biopsy devices for accurate diagnosis and staging.
• Increasing preference for minimally invasive procedures: Patients and doctors are increasingly choosing less invasive biopsy methods that reduce recovery time and complications.
• Government support for cancer screening programs: Public health initiatives and funding for early detection are encouraging wider use of biopsy devices in clinical settings.

Restraints

• High cost of advanced biopsy devices: Expensive equipment and procedures can limit adoption in cost-sensitive healthcare systems and among lower-income patients.
• Shortage of trained professionals: A lack of skilled specialists to operate advanced biopsy devices can restrict market growth in certain regions.

Biopsy Devices Market: Report Scope

Market Segmentation

The biopsy devices market can be segmented by product, guidance technique, application, end-use, and region.

Based on product, the market is segregated into needle-based biopsy instruments, biopsy guidance systems, and biopsy forceps. Needle-based biopsy instruments hold the largest share because they are widely used across breast, lung, and prostate biopsy procedures for their reliability and ease of use.

Based on the guidance technique, the biopsy devices market is divided into ultrasound-guided, stereotactic-guided, MRI-guided, and CT-guided biopsy devices. Ultrasound-guided biopsy leads the market because it offers real-time visualization, high accuracy, and lower cost compared to other imaging methods.

Based on application, the biopsy devices industry is classified into breast biopsy, lung biopsy, prostate biopsy, and colorectal biopsy. Breast biopsy accounts for the largest share of applications because breast cancer remains one of the most commonly diagnosed cancers worldwide, requiring frequent tissue sampling.

Based on end-use, the market is segmented into hospitals, diagnostic and imaging centers, and academic and research institutes. Hospitals lead the market as they have the infrastructure and specialist expertise required to perform complex biopsy procedures.

North America leads the global biopsy devices market due to advanced healthcare infrastructure, high cancer screening rates, and strong investment in diagnostic research, especially in the United States. Government-funded cancer research programs and a high volume of diagnostic procedures support the region's dominant position. The presence of leading medical device manufacturers and favorable reimbursement policies further strengthens market growth in North America. Increasing adoption of robotic-assisted and AI-supported biopsy technologies is enhancing procedural accuracy across the region. Rising awareness campaigns for early cancer detection continue to drive demand for biopsy devices among both patients and healthcare providers. Strong collaboration between hospitals and research institutions also supports the continuous development of advanced biopsy tools in this market.

Key Market Players

Leading companies in the global biopsy devices market include:

• Hologic Inc.
• Danaher Corporation (Leica Microsystem)
• B. Braun Melsungen AG
• Fujifilm Holdings Corp.
• Argon Medical Devices Inc.
• Becton Dickinson and Company (C.R. Bard Inc.)
• Boston Scientific Corporation
• Cardinal Health Inc.
• Cook Medical Inc.
• Medtronic plc

Recent Developments

• In February 2026, Mammotome launched the Mammotome Prima MR Dual Vacuum-Assisted Breast Biopsy System, the industry's first biopsy system designed to be positioned inside the MRI scanner room, improving workflow efficiency and patient care during MRI-guided breast biopsy procedures.

The global Biopsy Devices Market is segmented as follows:

By Product

• Core Needle Biopsy
• Aspiration Biopsy
• Vacuum Assisted Biopsy

By Application

• Breast Biopsy
• Prostrate Biopsy
• Lung Biopsy

By Region

• North America
  • The U.S.
  • Canada
• Europe
  • France
  • The UK
  • Spain
  • Germany
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Southeast Asia
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
• Middle East & Africa
  • GCC
  • South Africa
  • Rest of Middle East & Africa

About Us:
Zion Market Research is an obligated company. We create futuristic, cutting-edge, informative reports ranging from industry reports, company reports to country reports. We provide our clients not only with market statistics unveiled by avowed private publishers and public organizations but also with vogue and newest industry reports along with pre-eminent and niche company profiles. Our database of market research reports comprises a wide variety of reports from cardinal industries. Our database is updated constantly in order to provide our clients with prompt and direct online access to our database. Keeping in mind the client’s needs, we have included expert insights on global industries, products, and market trends in this database. Last but not least, we make it our duty to ensure the success of clients connected to us—after all, if you do well, a little of the light shines on us.

Contact Us:
Zion Market Research
244 Fifth Avenue, Suite N202
New York, 10001, United States
Tel: +49-322 210 92714
USA/Canada Toll-Free No.1-855-465-4651
Email: sales@zionmarketresearch.com
Website: https://www.zionmarketresearch.com